3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
3
Completed
2
Unknown
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Lymphoma
9
Hodgkin Disease
7
Testicular Neoplasms
3
Teratoma
3
Lymphoma, Large B-Cell, Diffuse
3
Recurrence
2
Ovarian Neoplasms
2
Ovarian Germ Cell Cancer
2
Warts
1
Vulvar Neoplasms
1
Testicular Germ Cell Tumor
1
Stomach Neoplasms
1
Sertoli-Leydig Cell Tumor
1
Seminoma
1
Sarcoma, Kaposi
1
Rectal Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pathologic Processes
1
Ovarian gynandroblastoma
1
Neoplastic Processes
1
Neoplasms
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large-Cell, Immunoblastic
1
Intracranial Non-germinomatous Germ Cell Tumor
1
Head and Neck Neoplasms
1
HIV Infections
1
Granulosa cell tumor of the ovary
1
Germinoma
1
Endodermal Sinus Tumor
1
Interventions
Exercise
19
Drug Therapy
18
pembrolizumab
13
Capecitabine
11
Blood Specimen Collection
11
Surveys and Questionnaires
10
Radiotherapy
10
Paclitaxel
9
Dexamethasone
9
Nivolumab
8
Standard of Care
7
Oxaliplatin
7
Fluorouracil
7
Erlotinib Hydrochloride
7
apatinib
6
Interviews as Topic
6
Gemcitabine
6
Control Groups
6
Cisplatin
6
Therapeutics
5
Neoadjuvant Therapy
5
Mindfulness-Based Cognitive Therapy
5
Metformin
5
Injections
5
Everolimus
5
Docetaxel
5
Cyclophosphamide
5
Bevacizumab
5
sintilimab
4
atezolizumab
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Neoplasms
×
Bleomycin
×
Clear all
NCT03040180
2019-01-25
nECT
Zealand University Hospital
Phase 2
Unknown
40 enrolled